BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 27026411)

  • 1. NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
    Ferrara G; Errede M; Girolamo F; Morando S; Ivaldi F; Panini N; Bendotti C; Perris R; Furlan R; Virgintino D; Kerlero de Rosbo N; Uccelli A
    Acta Neuropathol; 2016 Jul; 132(1):23-42. PubMed ID: 27026411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
    Girolamo F; Errede M; Longo G; Annese T; Alias C; Ferrara G; Morando S; Trojano M; Kerlero de Rosbo N; Uccelli A; Virgintino D
    PLoS One; 2019; 14(3):e0213508. PubMed ID: 30870435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression.
    Clarkson BD; Walker A; Harris MG; Rayasam A; Sandor M; Fabry Z
    J Immunol; 2015 Jan; 194(2):531-41. PubMed ID: 25505278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NG2-proteoglycan-dependent contributions of oligodendrocyte progenitors and myeloid cells to myelin damage and repair.
    Kucharova K; Stallcup WB
    J Neuroinflammation; 2015 Sep; 12():161. PubMed ID: 26338007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
    Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
    Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
    Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype.
    Milovanovic M; Volarevic V; Ljujic B; Radosavljevic G; Jovanovic I; Arsenijevic N; Lukic ML
    PLoS One; 2012; 7(9):e45225. PubMed ID: 23028861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation.
    Sagar D; Lamontagne A; Foss CA; Khan ZK; Pomper MG; Jain P
    J Neuroinflammation; 2012 Oct; 9():245. PubMed ID: 23102113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
    Clarkson BD; Walker A; Harris M; Rayasam A; Sandor M; Fabry Z
    J Neuroimmunol; 2014 Dec; 277(1-2):39-49. PubMed ID: 25288303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
    Chung CY; Liao F
    J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signaling.
    Tsiperson V; Gruber RC; Goldberg MF; Jordan A; Weinger JG; Macian F; Shafit-Zagardo B
    J Immunol; 2013 Feb; 190(4):1528-39. PubMed ID: 23335751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
    Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
    Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective depletion of CD11c
    Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
    Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-independent modulation of experimental autoimmune encephalomyelitis in ADAP-deficient mice.
    Engelmann S; Togni M; Thielitz A; Reichardt P; Kliche S; Reinhold D; Schraven B; Reinhold A
    J Immunol; 2013 Nov; 191(10):4950-9. PubMed ID: 24101551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
    Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
    J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis.
    Bullard DC; Hu X; Adams JE; Schoeb TR; Barnum SR
    Am J Pathol; 2007 Jun; 170(6):2001-8. PubMed ID: 17525267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes.
    Chen L; Brosnan CF
    J Immunol; 2006 Mar; 176(5):3115-26. PubMed ID: 16493071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.